B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity

Journal of Experimental Medicine

Volumn 196, Issue 10, 2002, Pages 1277-1290

  Tsuji, Ryohei F ^a   Szczepanik, Marian ^b   Kawikova, Ivana ^c   Paliwal, Vipin ^c   Campos, Regis A ^c   Itakura, Atsuko ^c   Akahira Azuma, Moe ^c   Baumgarth, Nicole ^d   Herzenberg, Leonore A ^e   Askenase, Philip W ^c  

^a Noda Institute for Scientific Research   (Japan)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

Complement C5 and C5a; IgM response; Skin immunity; T and B cell interactions; T cell recruitment

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; HAPTEN; IMMUNOGLOBULIN M; OXAZOLONE; PICRYL CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONTACT SENSITIVITY; CONTROLLED STUDY; EFFECTOR CELL; EVIDENCE BASED MEDICINE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN SENSITIZATION; SKIN TEST; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CELL SEPARATION; COMPLEMENT C5; DERMATITIS, CONTACT; FLOW CYTOMETRY; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED CBA; T-LYMPHOCYTES;

EID: 0037131979     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020649     Document Type: Article

References (59)

1. Askenase, P.W. 1998. Effector and regulatory molecules and mechanisms in delayed hypersensitivity. In Allergy: Principles and Practice 5th Edition. N.F. Adkinson, Jr., editor. Mosby Co., St. Louis. 323-341.
2. Marchal, G., M. Seman, G. Milon, P. Truffa-Bachi, and V. Zilberfarb. 1982. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J. Immunol. 129:954-958.
3. + T cell-mediated delayed hypersensitivity: Implications for allergies, asthma, and autoimmunity. J. Allergy Clin. Immunol. 103:192-199.
4. Fong, T.A., and T.R. Mosmann. 1989. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones. J. Immunol. 143:2887-2893.
5. Tsuji, R.F., M. Kikuchi, and P.W. Askenase. 1996. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity. J. Immunol. 156:4444-4450.
6. Tsuji, R.F., G.P. Geba, Y. Wang, K. Kawamoto, L.A. Matis, and P.W. Askenase. 1997. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: A possible initiating role of B cells. J. Exp. Med. 186: 1015-1026.
7. Tsuji, R.F., M. Uramoto, H. Koshino, N.M. Tsuji, J. Magae, K. Nagai, and M. Yamasaki. 1992. Preferential suppression of delayed-type hypersensitivity by L-156,602, a C5a receptor antagonist. Biosci. Biotechnol. Biochem. 56:1686-1689.
8. Tsuji, R.F., I. Kawikova, R. Ramabhadran, M. Akahira-Azuma, D. Taub, T.E. Hugli, C. Gerard, and P.W. Askenase. 2000. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165:1588-1598.
9. Askenase, P.W., I. Kawikova, V. Paliwal, M. Akahira-Azuma, C. Gerard, T. Hugli, and R. Tsuji. 1999. A new paradigm of T cell allergy: Requirement for the B-1 cell subset. Int. Arch. Allergy Appl. Immunol. 118:145-149.
10. Askenase, P.W., and R.F. Tsuji. 2000. B-1 B cell IgM anti-body initiates T cell elicitation of contact sensitivity. Curr. Top. Microbiol. Immunol. 252:171-179.
11. Chen, J., M. Trounstine, F.W. Alt, F. Young, C. Kurahara, J.F. Loring, and D. Huszar. 1993. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5:647-656.
12. Hardy, R.R., and K. Hayakawa. 1994. CD5 B cells, a fetal B cell lineage. Adv. Immunol. 55:297-339.
13. Wells, S.M., A.B. Kantor, and A.M. Stall. 1994. CD43 (S7) expression identified peripheral B cell subsets. J. Immunol. 153:5503-5515.
14. Ushio, H., R.F. Tsuji, M. Szczepanik, K. Kawamoto, H. Matsuda, and P.W. Askenase. 1998. IL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B7-1 (CD80) and B7-2 (CD86). J. Immunol. 160:2080-2088.
15. Van Loveren, H., and P.W. Askenase. 1984. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J. Immunol. 133:2397-2401.
16. Ptak, W., W.R. Herzog, and P.W. Askenase. 1991. Delayed- type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. J. Immunol. 146:469-475.
17. Hata, D., Y. Kawakami, N. Inagaki, C.S. Lantz, T. Kitamura, W.N. Khan, M. Maeda-Yamamoto, T. Miura, W. Han, S.E. Hartman, et al. 1998. Involvement of Bruton's tyrosine kinase in FcepsilonR1-dependent mast cell degranulation and cytokine production. J. Exp. Med. 187:1235-1247.
18. Mukhopadhyay, S., P.K. Sahoo, A. George, V. Bal, S. Rath, and B. Ravindran. 1999. Delayed clearance of filarial infection and enhanced Th1 immunity due to modulation of macrophage APC functions in xid mice. J. Immunol. 163:875-883.
19. Ptak, W., G.P. Geba, and P.W. Askenase. 1991. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J. Immunol. 146:3929-3936.
20. Askenase, P.W., S. Bursztajn, M.D. Gershon, and R.K. Gershon. 1980. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp. Med. 152:1358-1374.
21. Geba, G.P., W. Ptak, G.A. Anderson, R.E. Ratzlaff, J. Levin, and P.W. Askenase. 1996. Delayed-type hypersensitivity in mast cell deficient mice: Dependence on platelets for expression of contact sensitivity. J. Immunol. 157:557-565.
22. McHale, J.F., O.A. Harari, D. Marshall, and D.O. Haskard. 1999. Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: Evidence for a dominant role of TNF-α. J. Immunol. 162:1648-1655.
23. Bhutto, A.M., M. Honda, K. Maeda, S. Anan, and H. Yoshida. 1992. Contact hypersensitivity reaction to ovalbumin in newborn guinea pigs from maternally sensitized animals. J. Dermatol. Sci. 4:156-165.
24. 1 antibodies: Transfer of cutaneous basophil reactions. J. Immunol. 120:886- 894.
25. Moore, K.G., and A.M. Dannenberg, Jr. 1993. Immediate and delayed (late-phase) dermal contact sensitivity reactions in guinea pigs. Passive transfer by IgG1 antibodies, initiation by mast cell degranulation, and suppression by soybean proteinase inhibition. Int. Arch. Allergy Immunol. 101:72-81.
26. Grabbe, S., and T. Schwartz. 1998. Immunoregulatory mechanisms involved in elicitation of allergic contact hyper-sensitivity. Immunol. Today. 19:37-44.
27. Hayakawa, K., R.R. Hardy, L.A. Herzenberg, A.D. Steinberg, and L.A. Herzenberg. 1984. Ly-1 B: A functionally distinct B-cell subpopulation. In Progress of Immunology V. Academic Press, Tokyo. 661-668.
28. Silverman, G.J., S.P. Cary, D.C. Dwyer, L. Luo, R. Wagenknecht, and V.E. Curtiss. 2000. A B cell superantigen-induced persistent "hole" in the B-1 repertoire. J. Exp. Med. 192:87-98.
29. Shaw, P.X., S. Horkko, M.K. Chang, L.K. Curtiss, W. Palinski, G.J. Silverman, and J.L. Witztum. 2000. Natural anti-bodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105: 1731-1740.
30. + B lymphocytes. Int. Immunol. 2:515-520.
31. Briles, D.E., C. Forman, S. Hudak, and J.L. Claflin. 1982. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156:1177-1185.
32. Wallick, S., J.L. Claflin, and D.E. Briles. 1983. Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate. J. Immunol. 130:2871-2875.
33. Cunningham, A.J. 1974. Large numbers of cells in normal mice produce antibody components of isologous erythrocytes. Nature. 252:749-751.
34. Cunningham, A.J., and E.J. Steele. 1981. Ontogeny of the autoimmune reaction in normal mice to antigens in erythrocytes and gut. Clin. Exp. Immunol. 44:38-48.
35. Hayakawa, K., R.R. Hardy, M. Honda, L.A. Herzenberg, and A.D. Steinberg. 1984. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl. Acad. Sci. USA. 81:2494-2498.
36. Kerman, R., and D. Segre. 1970. Anti-pneumococcal polysaccharide type 3 hemolytic plaques in mice: Cellular response in immunity and immunologic paralysis. J. Immunol. 104:1262-1266.
37. Baker, P.H., and P.W. Stashak. 1969. Quantitative and qualitative studies on the primary, antibody response to pneumococcal polysaccharides at the cellular level. J. Immunol. 103: 1342-1348.
38. Fagarasan, S., K. Kinoshita, M. Muramatsu, K. Ikuta, and T. Honjo. 2001. In situ class switching and differentiation of IgA-producing cells in the gut lamina propria. Nature. 413: 639-643.
39. Watanabe, N., K. Ikuta, S. Fagarasan, S. Yazumi, T. Chiba, and T. Honjo. 2000. Migration and differentiation of autore-active B-1 cells induced by activated γ/δ T cells in antierythrocyte immunoglobulin transgenic mice. J. Exp. Med. 192: 1577-1586.
40. Pior, J., T. Vogl, C. Sorg, and E. Macher. 1999. Free hapten molecules are dispersed by way of the bloodstream during contact sensitization to fluorescein isothiocyanate. J. Invest. Dermatol. 113:888-893.
41. -/- mice have defective contact sensitivity (CS): the cause is absent IL-4 induced activation of CS-initiating B-1 cells. Immunology. 104:7 (Abstr.).
42. Askenase, P.W., M. Azuma-Akahira, M. Szczepanik, M. Kronenberg, and R. Campos. 2001. Liver NK T cells are activated early in contact sensitivity (CS) to release IL-4 that activates B-1 cells that initiate elicited responses. Immunology. 104:14 (Abstr.).
43. Svensson, L., J. Jirholt, R. Holmdahl, and L. Jansson. 1998. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111:521-526.
44. Akashi, T., S. Nagafuchi, K. Anzai, S. Kondo, D. Kitamura, S. Wakana, J. Ono, M. Kikuchi, Y. Niho, and T. Watanabe. 1997. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int. Immunol. 9:1159-1164.
45. Chan, O.T., M.P. Madaio, and M.J. Shlomchik. 1999. B cells are required for lupus nephritis in the polygenic, Fasintact MRL model of systemic autoimmunity. J. Immunol. 163:3592-3596.
46. Lyons, J.A., M. San, M.P. Happ, and A.H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:3432-3439.
47. Vordermeier, H.M., N. Venkataprasad, D.P. Harris, and J. Ivanyi. 1996. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin. Exp. Immunol. 106:312-316.
48. Yang, X., and R.C. Brunham. 1998. Gene knockout B cell- deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J. Immunol. 161:1439-1446.
49. Falcone, M., J. Lee, G. Patstone, B. Yeung, and N. Sarvetnick. 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response GAD65 antigen in nonobese diabetic mice. J. Immunol. 161:1163-1168.
50. Linington, C., B. Engelhardt, G. Kapocs, and H. Lassman. 1992. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol. 40: 219-224.
51. Litzenburger, T., R. Fassler, J. Bauer, H. Lassmann, C. Linington, H. Wekerle, and A. Iglesias. 1998. B lymphocytes producing demyelinating autoantibodies: Development and function in gene-targeted transgenic mice. J. Exp. Med. 188: 169-180.
52. Wang, Y., S.A. Rollins, J.A. Madri, and L.A. Matis. 1995. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. USA. 92:8955-8959.
53. Wang, Y., J. Kristan, L. Hao, C.S. Lenkoski, Y. Shen, and L.A. Matis. 2000. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J. Immunol. 164:4340-4347.
54. Dietsch, G.N., and D.J. Hinrichs. 1989. The role of mast cells in the elicitation of experimental allergic encephalomy-elitis. J. Immunol. 142:1476-1481.
55. Bebo, B.F., Jr., T. Yong, E.L. Orr, and D.S. Linthicum. 1996. Hypothesis: A possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 45:340-348.
56. Kakizoe, E., S.H. Li, Y. Kobayashi, Y. Nishikori, S. Dekio, and H. Okunishi. 1999. Increases in mast cells and chymase in fibroproliferative paws of collagen-induced arthritic mice. Inflamm. Res. 48:318-324.
57. Secor, V.H., W.E. Secor, C.A. Gutekunst, and M.A. Brown. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191: 813-822.
58. Gern, J.E., R.F. Lemanske, and W.W. Busse. 1999. Early life origins of asthma. J. Clin. Invest. 104:837-843.
59. Regner, M., and P.H. Lambert. 2001. Autoimmunity through infection or immunization? Nat. Immunol. 2:185-188.